Medicare Enrolled

Dr. Denzil D'Souza, M.D.

Cardiovascular Disease · Fort Worth, TX
Practice pattern: Cardiac Imaging— Practice with significant diagnostic imaging and stress testing
Low-engagement
1900 MISTLETOE BLVD, Fort Worth, TX 76104
8173381300
In practice since 2005 (20 years)
NPI: 1457337057 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. D'Souza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. D'Souza? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. D'Souza

Dr. Denzil D'Souza is a cardiovascular disease in Fort Worth, TX, with 20 years in practice. Based on federal Medicare data, Dr. D'Souza performed 3,094 Medicare services across 2,182 unique beneficiaries.

Between the years covered by Open Payments, Dr. D'Souza received a total of $9,604 from 22 pharmaceutical and/or device companies across 116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. D'Souza is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 33% volume in TX$ $9,604 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,094
Medicare services
Top 33% in TX for cardiovascular disease
2,182
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~155 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Regadenoson injection (Lexiscan) for heart stress test444$41$120
Electrocardiogram (EKG), 12-lead362$10$42
Office visit, established patient (30-39 min)334$91$231
Hospital follow-up visit, high complexity228$92$224
Prothrombin time test (blood clotting)206$4$13
Office visit, established patient, complex (40-54 min)196$128$310
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician161$49$196
Echocardiogram, transthoracic156$142$471
Nuclear medicine studies of heart muscle at rest and with stress and spect143$334$1,111
Technetium tc-99m tetrofosmin, diagnostic, per study dose140$156$233
Hospital follow-up visit, moderate complexity122$61$155
Initial hospital admission, high complexity68$135$434
New patient office visit (45-59 min)67$111$355
Telephone medical discussion with physician, 21-30 minutes65$94$130
Office visit, established patient (20-29 min)57$66$156
Telephone medical discussion with physician, 11-20 minutes43$69$95
New patient office visit, complex (60-74 min)39$160$442
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes38$10$150
Chronic care management, first 20 min/month37$47$95
Cardiac catheterization32$194$600
Ultrasound of both sides of head and neck blood flow25$112$444
Chronic care management, additional 20 min/month24$37$92
Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month22$66$120
Nuclear medicine studies of blood flow in heart muscle at rest and with stress20$1,061$2,490
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries20$785$1,200
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)18$48$120
Hospital follow-up visit, low complexity14$39$85
Coronary stent placement13$424$1,280
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.5% high complexity
25.6% medium
67.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,604
Total received (2018-2024)
Avg $1,372/year across 7 years
Top 33% in TX for cardiovascular disease
22
Companies
116
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,407 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$196 (2.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,075
2023
$3,977
2022
$159
2021
$169
2020
$219
2019
$1,649
2018
$356

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$2,563
Penumbra, Inc.
$2,440
Abbott Laboratories
$1,646
ABIOMED
$1,610
Amgen Inc.
$178
E.R. Squibb & Sons, L.L.C.
$161
PFIZER INC.
$145
BIOTRONIK INC.
$124
Actelion Pharmaceuticals US, Inc.
$122
Medtronic Vascular, Inc.
$113
AstraZeneca Pharmaceuticals LP
$105
SANOFI-AVENTIS U.S. LLC
$99
Novartis Pharmaceuticals Corporation
$95
Amarin Pharma Inc.
$36
Novo Nordisk Inc
$30
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$25
Janssen Pharmaceuticals, Inc
$25
ZOLL Circulation Inc
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Avinger Inc.
$19
Saranas, Inc.
$16
BOSTON SCIENTIFIC CORPORATION
$11
Top 3 companies account for 69.2% of total payments
Associated products mentioned in payments ›
AVEIR · BRILINTA · CAMZYOS · CARDIOMEMS · CoreValve Evolut · Corlanor · ELIQUIS · ENTRESTO · FARXIGA · Impella · Indigo System · LifeVest · MULTAQ · Mitra Clip system · ONYX FRONTIER · OPSUMIT · OPTIS · Orsiro Mission · Ozempic · PANTHERIS · PRADAXA · PRALUENT · Quadra Assura CRT Defibrillator · Repatha · SPECTRA WAVEWRITER · SYMPLICITY G3 · Temperature Management System · TherOx DS2 Console · Tresiba · UPTRAVI · VYNDAQEL · Vascepa · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $310 per 100 Medicare services performed
Looking for a cardiovascular disease in Fort Worth?
Compare cardiovascular diseases in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
102
Per 100K population
4.8
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. D'Souza is a cardiac imaging specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. D'Souza experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. D'Souza performed 444 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. D'Souza receive payments from pharmaceutical companies?
Yes. Dr. D'Souza received a total of $9,604 from 22 companies across 116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. D'Souza's costs compare to other cardiovascular diseases in Fort Worth?
Dr. D'Souza's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. D'Souza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →